NEUROTHERAPEUTICS LTD

13198315
Active Nottingham

Manufacture of irradiation, electromedical and electrotherapeutic equipment

11 employees website.com
Healthcare and wellbeing Manufacture of irradiation, electromedical and electrotherapeutic equipment
N

NEUROTHERAPEUTICS LTD

13198315

Manufacture of irradiation, electromedical and electrotherapeutic equipment

Founded 12 Feb 2021 Active Nottingham, England 11 employees website.com
Healthcare and wellbeing Manufacture of irradiation, electromedical and electrotherapeutic equipment

Previous Company Names

NEUROTHERAPEUTICS SOLUTIONS LIMITED 12 Feb 2021 — 7 Oct 2021
Accounts Submitted 28 Apr 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 21 Feb 2026 Next due 24 Feb 2027 8 months remaining
Net assets £1M £1M 2025 year on year
Total assets £1M £982K 2025 year on year
Total Liabilities £246K £142K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Ingenuity Centre University Of Nottingham Innovation Park Triumph Road Nottingham NG7 2TU England

Email

info@example.com

Website

www.example.com

Full company profile for NEUROTHERAPEUTICS LTD (13198315), an active healthcare and wellbeing company based in Nottingham, England. Incorporated 12 Feb 2021. Manufacture of irradiation, electromedical and electrotherapeutic equipment. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2025)

Cash in Bank

£947.08k

Decreased by £1.05M (-53%)

Net Assets

£1.08M

Decreased by £1.12M (-51%)

Total Liabilities

£246.21k

Increased by £141.95k (+136%)

Turnover

N/A

Employees

11

Increased by 2 (+22%)

Debt Ratio

19%

Increased by 14 (+280%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Dec Year End
2024
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 5Aug 2021Seed
Investor 6Aug 2021Seed
Investor 3Mar 2024Seed

Share Capital

Share Capital

Share allotments and capital structure

13 Allotments 228,922 Shares £7.68m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
13 Apr 20265,052£213k£42.22
21 Jan 202670,508£2.98m£42.22
12 May 20251,404£15.444£0.011
12 May 20252,000£22£0.011
12 May 20252,840£31.24£0.011

Officers

Officers

2 active 1 resigned
Status
Jackson, Georgina Margaret, ProfessorDirectorBritishEngland6912 Feb 2021Active
Maiquez, Barbara Morera, DrDirectorSpanishEngland351 Dec 2022Active

Shareholders

Shareholders (80)

University Of Nottingham
15.3%
52,554
Mrv (general Partner Meif Ii - Equity Em) Limited
10.6%
36,349

Persons with Significant Control

Persons with Significant Control (0)

0 Active 3 Ceased

Professor Georgina Margaret Jackson

Ceased 5 Aug 2021

Ceased

Professor Stephen Raymond Jackson

Ceased 5 Aug 2021

Ceased

Barbara Morera Maiquez

Ceased 5 Aug 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Apr 2026CapitalAllotment of shares (GBP 2,867.19862) on 21 Apr 2026
28 Apr 2026AccountsAnnual accounts made up to 31 Dec 2025
18 Mar 2026OfficersTermination of Andrew Paul Mcneill as director on 16 Mar 2026
21 Feb 2026Confirmation StatementConfirmation statement made on 10 Feb 2026 with updates
10 Feb 2026CapitalAllotment of shares (GBP 2,810.67862) on 6 Feb 2026
30 Apr 2026 Capital

Allotment of shares (GBP 2,867.19862) on 21 Apr 2026

28 Apr 2026 Accounts

Annual accounts made up to 31 Dec 2025

18 Mar 2026 Officers

Termination of Andrew Paul Mcneill as director on 16 Mar 2026

21 Feb 2026 Confirmation Statement

Confirmation statement made on 10 Feb 2026 with updates

10 Feb 2026 Capital

Allotment of shares (GBP 2,810.67862) on 6 Feb 2026

Recent Activity

Latest Activity

Allotment of shares (GBP 2,867.19862) on 21 Apr 2026

1 months ago on 30 Apr 2026

Annual accounts made up to 31 Dec 2025

1 months ago on 28 Apr 2026

Termination of Andrew Paul Mcneill as director on 16 Mar 2026

2 months ago on 18 Mar 2026

Confirmation statement made on 10 Feb 2026 with updates

3 months ago on 21 Feb 2026

Allotment of shares (GBP 2,810.67862) on 6 Feb 2026

4 months ago on 10 Feb 2026